Ischemia Care Biomarkers of Acute Stroke Etiology (BASE)
The proposed study will validate the clinical use of new biomarker blood tests to identify blood components that may differentiate between diverse stroke etiologies and clinical outcomes.
-Arrival to the ED or hospital within 8 hours of symptom onset or last known normal time.
-Head CT or MRI ruling out other pathology.
**Other protocol-defined inclusion/exclusion criteria may apply. Please click on the NCT Number (below) to learn more about the study at clinicaltrials.gov.**
Ted Lowenkopf, M.D.
Ischemia Care, LLC
- Providence Portland Medical Center
- Providence St. Vincent Medical Center